Low FODMAP diet beyond IBS: Evidence for use in other conditions

Jessica R. Biesiekierski, Caroline J. Tuck

Research output: Contribution to journalReview ArticleResearchpeer-review

6 Citations (Scopus)


The low FODMAP diet has shifted therapeutic guidelines for symptom management in irritable bowel syndrome. Given FODMAPs are involved in underlying pathological mechanisms of visceral hypersensitivity, research groups are exploring the use of the low-FODMAP diet as a potential management approach in several conditions outside of irritable bowel syndrome. Early data shows promise for functional dyspepsia, improving epigastric symptoms, and although evidence is scant, the diet has been proposed to assist in small intestinal bacterial overgrowth. Characterisation of sucrase–isomaltase deficiency may offer profiling for predicting response to the diet. Although encouraging, carefully controlled broader trials are needed across the conditions discussed to completely understand the effects of the low FODMAP diet on symptoms, safety, and efficacy in clinical practice.

Original languageEnglish
Article number102208
Number of pages9
JournalCurrent Opinion in Pharmacology
Publication statusPublished - Jun 2022

Cite this